222 related articles for article (PubMed ID: 8505288)
21. Synaptobrevin/vesicle-associated membrane protein (VAMP) of Aplysia californica: structure and proteolysis by tetanus toxin and botulinal neurotoxins type D and F.
Yamasaki S; Hu Y; Binz T; Kalkuhl A; Kurazono H; Tamura T; Jahn R; Kandel E; Niemann H
Proc Natl Acad Sci U S A; 1994 May; 91(11):4688-92. PubMed ID: 8197120
[TBL] [Abstract][Full Text] [Related]
22. The metallo-proteinase activity of tetanus and botulism neurotoxins.
Rossetto O; Deloye F; Poulain B; Pellizzari R; Schiavo G; Montecucco C
J Physiol Paris; 1995; 89(1):43-50. PubMed ID: 7581298
[TBL] [Abstract][Full Text] [Related]
23. Botulinum neurotoxin types A, B, and E: fragmentations by autoproteolysis and other mechanisms including by O-phenanthroline-dithiothreitol, and association of the dinucleotides NAD(+)/NADH with the heavy chain of the three neurotoxins.
Dasgupta BR; Antharavally BS; Tepp W; Evenson ML
Protein J; 2005 Aug; 24(6):337-68. PubMed ID: 16323041
[TBL] [Abstract][Full Text] [Related]
24. Botulinum A like type B and tetanus toxins fulfils criteria for being a zinc-dependent protease.
de Paiva A; Ashton AC; Foran P; Schiavo G; Montecucco C; Dolly JO
J Neurochem; 1993 Dec; 61(6):2338-41. PubMed ID: 8245989
[TBL] [Abstract][Full Text] [Related]
25. Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity.
Schmidt JJ; Stafford RG
Biochemistry; 2005 Mar; 44(10):4067-73. PubMed ID: 15751983
[TBL] [Abstract][Full Text] [Related]
26. Substrate residues N-terminal to the cleavage site of botulinum type B neurotoxin play a role in determining the specificity of its endopeptidase activity.
Wictome M; Rossetto O; Montecucco C; Shone CC
FEBS Lett; 1996 May; 386(2-3):133-6. PubMed ID: 8647267
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation of VAMP/synaptobrevin in synaptic vesicles by endogenous protein kinases.
Nielander HB; Onofri F; Valtorta F; Schiavo G; Montecucco C; Greengard P; Benfenati F
J Neurochem; 1995 Oct; 65(4):1712-20. PubMed ID: 7561869
[TBL] [Abstract][Full Text] [Related]
28. Exogenous zinc ion is required for inhibitory activity of botulinum neurotoxin C1 against norepinephrine release and its endopeptidase activity toward substance P.
Yokosawa N; Suga K; Kimura K; Tsuzuki K; Fujii N; Oguma K; Yokosawa H
Biochem Mol Biol Int; 1994 Mar; 32(3):455-63. PubMed ID: 7518276
[TBL] [Abstract][Full Text] [Related]
29. Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities.
Hallis B; James BA; Shone CC
J Clin Microbiol; 1996 Aug; 34(8):1934-8. PubMed ID: 8818885
[TBL] [Abstract][Full Text] [Related]
30. Botulinum neurotoxin types A and E require the SNARE motif in SNAP-25 for proteolysis.
Washbourne P; Pellizzari R; Baldini G; Wilson MC; Montecucco C
FEBS Lett; 1997 Nov; 418(1-2):1-5. PubMed ID: 9414082
[TBL] [Abstract][Full Text] [Related]
31. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
[TBL] [Abstract][Full Text] [Related]
32. Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 A resolution.
Hanson MA; Stevens RC
Nat Struct Biol; 2000 Aug; 7(8):687-92. PubMed ID: 10932255
[TBL] [Abstract][Full Text] [Related]
33. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins.
Binz T; Blasi J; Yamasaki S; Baumeister A; Link E; Südhof TC; Jahn R; Niemann H
J Biol Chem; 1994 Jan; 269(3):1617-20. PubMed ID: 8294407
[TBL] [Abstract][Full Text] [Related]
34. Identification of the amino acid residues rendering TI-VAMP insensitive toward botulinum neurotoxin B.
Sikorra S; Henke T; Swaminathan S; Galli T; Binz T
J Mol Biol; 2006 Mar; 357(2):574-82. PubMed ID: 16430921
[TBL] [Abstract][Full Text] [Related]
35. Clostridial neurotoxins as tools to investigate the molecular events of neurotransmitter release.
Schiavo G; Rossetto O; Montecucco C
Semin Cell Biol; 1994 Aug; 5(4):221-9. PubMed ID: 7994006
[TBL] [Abstract][Full Text] [Related]
36. Antibodies against rat brain vesicle-associated membrane protein (synaptobrevin) prevent inhibition of acetylcholine release by tetanus toxin or botulinum neurotoxin type B.
Poulain B; Rossetto O; Deloye F; Schiavo G; Tauc L; Montecucco C
J Neurochem; 1993 Sep; 61(3):1175-8. PubMed ID: 8395562
[TBL] [Abstract][Full Text] [Related]
37. Botulinum neurotoxin E-insensitive mutants of SNAP-25 fail to bind VAMP but support exocytosis.
Washbourne P; Bortoletto N; Graham ME; Wilson MC; Burgoyne RD; Montecucco C
J Neurochem; 1999 Dec; 73(6):2424-33. PubMed ID: 10582602
[TBL] [Abstract][Full Text] [Related]
38. Structure and function of tetanus and botulinum neurotoxins.
Montecucco C; Schiavo G
Q Rev Biophys; 1995 Nov; 28(4):423-72. PubMed ID: 8771234
[TBL] [Abstract][Full Text] [Related]
39. Exploring the functional domain and the target of the tetanus toxin light chain in neurohypophysial terminals.
Dayanithi G; Stecher B; Höhne-Zell B; Yamasaki S; Binz T; Weller U; Niemann H; Gratzl M
Neuroscience; 1994 Jan; 58(2):423-31. PubMed ID: 8152548
[TBL] [Abstract][Full Text] [Related]
40. Enzymatic profiling of tetanus and botulinum neurotoxins based on vesicle-associated-membrane protein derived fluorogenic substrates.
Perpetuo EA; Juliano L; Juliano MA; Fratelli F; Prado SM; Pimenta DC; Lebrun I
Protein Pept Lett; 2008; 15(10):1100-6. PubMed ID: 19075822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
